• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋生物作为生物活性环二肽的丰富来源。

Marine Organisms as a Prolific Source of Bioactive Depsipeptides.

机构信息

School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.

College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.

出版信息

Mar Drugs. 2023 Feb 11;21(2):120. doi: 10.3390/md21020120.

DOI:10.3390/md21020120
PMID:36827161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9966715/
Abstract

Depsipeptides, an important group of polypeptides containing residues of hydroxy acids and amino acids linked together by amide and ester bonds, have potential applications in agriculture and medicine. A growing body of evidence demonstrates that marine organisms are prolific sources of depsipeptides, such as marine cyanobacteria, sponges, mollusks, microorganisms and algae. However, these substances have not yet been comprehensively summarized. In order to enrich our knowledge about marine depsipeptides, their biological sources and structural features, as well as bioactivities, are highlighted in this review after an extensive literature search and data analysis.

摘要

深海肤肽是一类重要的多肽,其由通过酰胺键和酯键连接的羟基酸和氨基酸残基组成,在农业和医学领域具有广泛的应用前景。越来越多的证据表明,海洋生物是深海肤肽的丰富来源,如海洋蓝藻、海绵、软体动物、微生物和藻类。然而,这些物质尚未得到全面总结。为了丰富我们对海洋深海肤肽的认识,本文在广泛的文献检索和数据分析的基础上,重点介绍了其生物来源、结构特征和生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/e4c6dc9f44b0/marinedrugs-21-00120-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/f148b0a23a96/marinedrugs-21-00120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/bb2296290703/marinedrugs-21-00120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/3c8987d4aef2/marinedrugs-21-00120-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/4018bb5f52fd/marinedrugs-21-00120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/77eaf8195ec8/marinedrugs-21-00120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/73365de99ef7/marinedrugs-21-00120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/20d7aa6be675/marinedrugs-21-00120-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/e6d2a5b0ed26/marinedrugs-21-00120-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/fa4af5f0df06/marinedrugs-21-00120-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/632c74c7fbdc/marinedrugs-21-00120-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/60881f37e922/marinedrugs-21-00120-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/e4c6dc9f44b0/marinedrugs-21-00120-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/f148b0a23a96/marinedrugs-21-00120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/bb2296290703/marinedrugs-21-00120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/3c8987d4aef2/marinedrugs-21-00120-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/4018bb5f52fd/marinedrugs-21-00120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/77eaf8195ec8/marinedrugs-21-00120-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/73365de99ef7/marinedrugs-21-00120-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/20d7aa6be675/marinedrugs-21-00120-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/e6d2a5b0ed26/marinedrugs-21-00120-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/fa4af5f0df06/marinedrugs-21-00120-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/632c74c7fbdc/marinedrugs-21-00120-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/60881f37e922/marinedrugs-21-00120-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fc/9966715/e4c6dc9f44b0/marinedrugs-21-00120-g012.jpg

相似文献

1
Marine Organisms as a Prolific Source of Bioactive Depsipeptides.海洋生物作为生物活性环二肽的丰富来源。
Mar Drugs. 2023 Feb 11;21(2):120. doi: 10.3390/md21020120.
2
Marine Depsipeptides as Promising Pharmacotherapeutic Agents.海洋环肽作为有前景的药物治疗剂。
Curr Protein Pept Sci. 2017;18(1):72-91. doi: 10.2174/1389203717666160526122130.
3
Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals.具有抗癌潜力的生物活性肽和去肽:来自海洋动物的来源。
Mar Drugs. 2012 May;10(5):963-986. doi: 10.3390/md10050963. Epub 2012 Apr 26.
4
Benderamide A, a Cyclic Depsipeptide from a Singapore Collection of Marine Cyanobacterium cf. sp.苯并噻嗪酰胺 A,一种来源于海洋蓝细菌 cf. sp. 的新加坡采集物的环二肽
Mar Drugs. 2018 Oct 26;16(11):409. doi: 10.3390/md16110409.
5
Structures and Activities of Tiahuramides A-C, Cyclic Depsipeptides from a Tahitian Collection of the Marine Cyanobacterium Lyngbya majuscula.Tiahuramides A-C 的结构和活性,来自塔希提海域蓝藻 Lyngbya majuscula 采集物的环状缩肽。
J Nat Prod. 2018 Jun 22;81(6):1301-1310. doi: 10.1021/acs.jnatprod.7b00751. Epub 2018 May 24.
6
Portobelamides A and B and Caciqueamide, Cytotoxic Peptidic Natural Products from a sp. Marine Cyanobacterium.来自一种海洋蓝藻细菌的细胞毒性肽类天然产物——波托贝酰胺A、B和卡西克酰胺
J Nat Prod. 2021 Aug 27;84(8):2081-2093. doi: 10.1021/acs.jnatprod.0c01383. Epub 2021 Jul 16.
7
Synthesis and Preliminary Biological Evaluation of Two Fluoroolefin Analogs of Largazole Inspired by the Structural Similarity of the Side Chain Unit in Psammaplin A.受沙巴嗪 A 侧链单元结构相似性的启发,设计并合成了两种 largazole 的氟代烯烃类似物,并对其进行了初步的生物评价。
Mar Drugs. 2019 Jun 3;17(6):333. doi: 10.3390/md17060333.
8
Asymmetric Synthesis of the C15⁻C32 Fragment of Alotamide and Determination of the Relative Stereochemistry.不对称合成 Alotamide 的 C15⁻C32 片段及相对立体化学的确定。
Mar Drugs. 2018 Oct 30;16(11):414. doi: 10.3390/md16110414.
9
Biochemical studies of the lagunamides, potent cytotoxic cyclic depsipeptides from the marine cyanobacterium Lyngbya majuscula. Laguna 酰胺的生化研究,一种来自海洋蓝藻 Lyngbya majuscula 的强效细胞毒性环状缩肽。
Mar Drugs. 2012 May;10(5):1126-1137. doi: 10.3390/md10051126. Epub 2012 May 23.
10
Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula.从 Palmyra 环礁收集的海洋蓝细菌 Lyngbya majuscula 中分离得到的环肽 Palmyramide A。
J Nat Prod. 2010 Mar 26;73(3):393-8. doi: 10.1021/np900428h.

引用本文的文献

1
Neurobiological and Chemical Characterization of the Cyanobacterial Metabolite Veraguamide E.蓝藻代谢产物维拉瓜胺E的神经生物学和化学特征
bioRxiv. 2025 Jun 22:2025.06.19.660581. doi: 10.1101/2025.06.19.660581.
2
Isolation and Bioassay of Linear Veraguamides from a Marine Cyanobacterium ( sp.).从一种海洋蓝藻(属)中分离线性维拉瓜胺并进行生物测定。
Molecules. 2025 Feb 4;30(3):680. doi: 10.3390/molecules30030680.
3
Novel Insights into the Nobilamide Family from a Deep-Sea : Chemical Diversity, Biosynthesis and Antimicrobial Activity Towards Multidrug-Resistant Bacteria.

本文引用的文献

1
Exploring Marine as a Rich Source of Bioactive Peptides: Challenges and Opportunities from Marine Pharmacology.探索海洋作为生物活性肽的丰富来源:来自海洋药理学的挑战与机遇。
Mar Drugs. 2022 Mar 13;20(3):208. doi: 10.3390/md20030208.
2
Recent advances and limitations in the application of kahalalides for the control of cancer.kahalalides在癌症控制应用中的最新进展与局限性
Biomed Pharmacother. 2022 Apr;148:112676. doi: 10.1016/j.biopha.2022.112676. Epub 2022 Feb 8.
3
Triproamide and Pemukainalides, Cyclic Depsipeptides from the Marine Cyanobacterium .
来自深海的诺比酰胺家族新见解:化学多样性、生物合成及对多重耐药细菌的抗菌活性
Mar Drugs. 2025 Jan 14;23(1):41. doi: 10.3390/md23010041.
4
Marine Peptides: Potential Basic Structures for the Development of Hybrid Compounds as Multitarget Therapeutics for the Treatment of Multifactorial Diseases.海洋肽:作为治疗多因素疾病的多靶点治疗药物的杂合化合物开发的潜在基本结构。
Int J Mol Sci. 2024 Nov 23;25(23):12601. doi: 10.3390/ijms252312601.
5
The Epiphyte sp. G2112 Produces a Large Diversity of Nobilamide Peptides That Promote Biofilm Formation in Pseudomonads and .该附生菌 sp. G2112 产生大量多样的诺比尔酰胺肽,可促进假单胞菌生物膜的形成。
Biomolecules. 2024 Oct 1;14(10):1244. doi: 10.3390/biom14101244.
6
Marine bioactive peptides with anticancer potential, a narrative review.具有抗癌潜力的海洋生物活性肽:一篇综述
Int J Biochem Mol Biol. 2024 Aug 25;15(4):118-126. doi: 10.62347/TUVQ7468. eCollection 2024.
7
Computational Discovery of Marine Molecules of the Cyclopeptide Family with Therapeutic Potential.具有治疗潜力的环肽家族海洋分子的计算发现
Pharmaceuticals (Basel). 2023 Sep 28;16(10):1377. doi: 10.3390/ph16101377.
8
Recent Advances in Polypeptide Antibiotics Derived from Marine Microorganisms.海洋微生物来源的多肽抗生素研究进展。
Mar Drugs. 2023 Oct 22;21(10):547. doi: 10.3390/md21100547.
9
Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics.海洋无脊椎动物抗菌肽及其作为新型肽抗生素的潜力。
Mar Drugs. 2023 Sep 23;21(10):503. doi: 10.3390/md21100503.
10
Recent advances on cyclodepsipeptides: biologically active compounds for drug research.环缩酚酸肽的最新进展:用于药物研究的生物活性化合物
Front Microbiol. 2023 Oct 2;14:1276928. doi: 10.3389/fmicb.2023.1276928. eCollection 2023.
来自海洋蓝藻的环缩肽——曲普酰胺和培木卡那肽
J Nat Prod. 2022 Mar 25;85(3):485-492. doi: 10.1021/acs.jnatprod.1c00996. Epub 2022 Jan 14.
4
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).罗米地辛联合CHOP方案与CHOP方案治疗初治外周T细胞淋巴瘤患者的疗效比较:Ro-CHOP III期研究(由LYSA组织开展)结果
J Clin Oncol. 2022 Jan 20;40(3):242-251. doi: 10.1200/JCO.21.01815. Epub 2021 Nov 29.
5
Marine drugs: Biology, pipelines, current and future prospects for production.海洋药物:生物、管道、当前和未来的生产前景。
Biotechnol Adv. 2022 Jan-Feb;54:107871. doi: 10.1016/j.biotechadv.2021.107871. Epub 2021 Nov 19.
6
Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.OBP-801 是一种环状脱肽类 I 类组蛋白去乙酰化酶抑制剂,在晚期实体瘤患者中的 Ia 期剂量递增研究。
Invest New Drugs. 2022 Apr;40(2):300-307. doi: 10.1007/s10637-021-01180-9. Epub 2021 Oct 6.
7
Trikoveramides A-C, cyclic depsipeptides from the marine cyanobacterium Symploca hydnoides.特里克沃酰胺 A-C,来自海洋蓝细菌 Symploca hydnoides 的环状衍生肽。
Phytochemistry. 2021 Oct;190:112879. doi: 10.1016/j.phytochem.2021.112879. Epub 2021 Jul 14.
8
Natural Cyclopeptides as Anticancer Agents in the Last 20 Years.近 20 年来天然环肽类化合物作为抗癌药物的研究进展
Int J Mol Sci. 2021 Apr 12;22(8):3973. doi: 10.3390/ijms22083973.
9
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.联合口服 5-氮杂胞苷和罗米地辛对 PTCL 患者具有高度疗效:一项多中心 2 期研究。
Blood. 2021 Apr 22;137(16):2161-2170. doi: 10.1182/blood.2020009004.
10
Verrucosamide, a Cytotoxic 1,4-Thiazepane-Containing Thiodepsipeptide from a Marine-Derived Actinomycete.海洋来源放线菌中含 1,4-噻嗪烷的细胞毒硫酯肽类化合物疣粒衫醇。
Mar Drugs. 2020 Nov 5;18(11):549. doi: 10.3390/md18110549.